6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
ERA-NET: Aligning national/regional translational cancer research programmes and activities (TRANSCAN-2)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Voir le projet
30
Participants partenaires
TERMINÉ
Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy (MAGICBULLET)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,
Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are suitable as homing devices in tumor therapy. Conjugates of anticancer drugs with such a delivery vector targeting tumors would be a “magic bullet” according to the Nobel laureate Paul Ehrlich. Three antibody-drug conjugates (ADC) have already been approved for an ...
Voir le projet
9
Participants partenaires
TERMINÉ
A European Platform for Translational Cancer Research (EUROCANPLATFORM)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2016,
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer research and stressed the need to improve collaboration between basic/preclinical and comprehensive cancer centres (CCCs), in ...
Voir le projet
29
Participants partenaires
TERMINÉ
Roles of Hydrogen Sulfide and its Metabolites in Neutrophil Function and Redox Signaling (NHS)
Date du début: 1 juin 2011, Date de fin: 31 mai 2015,
"Inflammation is a fundamental pathological event, which is described as a protective response to abnormal stimulus. However it is also responsible for a plethora of inflammatory diseases. A major role of hydrogen sulfide is suggested in inflammation, but published results are controversial. In large quantities it is toxic, but it is also produced inside the body during the metabolism of the amino ...
Voir le projet
1
Participant partenaire
TERMINÉ
ERA-NET on Translational Cancer Research (TRANSCAN)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,
"Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of inte ...
Voir le projet
29
Participants partenaires
TERMINÉ
Regionale Zusammenarbeit für Ionentherapie (RegIonCo)
Date du début: 30 juin 2008, Date de fin: 30 mars 2012,
Nahe der österreichisch-ungarischen Grenze wird in Wiener Neustadt die mitteleuropäische Ionenbestrahlungsanlage MedAustron errichtet, die einerseits der Behandlung von Tumorpatienten dient, andererseits klinische und nichtklinische Forschungsaktivitäten ermöglichen soll. Um die positiven regionalen Auswirkungen dieser medizinischen Hightech-Anlage optimal nutzen zu können, erfolgt im Rahmen des ö ...
Voir le projet